ARCHIVES

NCAB Committee Approves Recompletion Of Support Contracts

This article is from The Cancer Letter archive.

Vol. 14 No. 39 | October 7, 1988

Download PDF Visit The Full Archive

Related Articles

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

November 27, 1998

Barnett Kramer Next Director Of NCI Division of Cancer Prevention

July 29, 2011

In Brief: Proposed Drug Act Revisions Would Provide Quick Approval Of “Breakthroughs,” IND_NDA Changes

March 24, 1978

“Do What’s Right for People With Cancer”. Glick’s Credo

May 24, 1996

NCI-Approved Clinical Trials

January 26, 2007

NCAB Study Core Guideline Revisions; Final Decision To Await New Division BSC

May 23, 1980